ORAL CARE COMPOSITION
The present application relates to a composition having a pH at 20°C from 4 to 6 and comprising: i) a quaternary ammonium compound selected from cetylpyridinium chloride (CPC), cetyltrimethylammonium chloride (CTAC), cetyltrimethylammonium bromide (CTAB), benzalkonium chloride (BKC), ii) a PEG hydro...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present application relates to a composition having a pH at 20°C from 4 to 6 and comprising: i) a quaternary ammonium compound selected from cetylpyridinium chloride (CPC), cetyltrimethylammonium chloride (CTAC), cetyltrimethylammonium bromide (CTAB), benzalkonium chloride (BKC), ii) a PEG hydrogenated castor oil; in which the quaternary ammonium compound and the PEG hydrogenated castor oil are present as a co-micelles. |
---|